Transient elastography in hepatitis C virus-infected patients with beta-thalassemia for assessment of fibrosis

Hepatology Research

Volumn 43, Issue 12, 2013, Pages 1276-1283

  Poustchi, Hossein ^a   Eslami, Masoomeh ^b   Ostovaneh, Mohammad Reza ^a   Modabbernia, Amirhossein ^a   Saeedian, Fatemeh Sima ^b   Taslimi, Shervin ^a   George, Jacob ^c   Malekzadeh, Reza ^a   Zamani, Farhad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hepatitis C virus; Liver cirrhosis; Liver iron content; Thalassemia; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN;

ADULT; ARTICLE; BETA THALASSEMIA; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPH; ELASTOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NEEDLE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THALASSEMIA MAJOR; THROMBOCYTE; TRANSIENT ELASTOGRAPHY; YOUNG ADULT;

EID: 84890918442     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12088     Document Type: Article

References (34)

1. Di Marco V, Bronte F, Cabibi D etal. Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Br J Haematol 2010; 148 (3): 476-479.
2. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41 (1): 48-54.
3. Coco B, Oliveri F, Maina AM etal. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14 (5): 360-369.
4. Fraquelli M, Rigamonti C, Casazza G etal. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56 (7): 968-973.
5. Rigamonti C, Donato MF, Fraquelli M etal. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut 2008; 57 (6): 821-827.
6. Arena U, Vizzutti F, Corti G etal. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47 (2): 380-384.
7. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48 (5): 835-847.
8. Castera L, Vergniol J, Foucher J etal. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128 (2): 343-350.
9. Foucher J, Chanteloup E, Vergniol J etal. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55 (3): 403-408.
10. Ganne-Carrie N, Ziol M, de Ledinghen V etal. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44 (6): 1511-1517.
11. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2007; 5 (10): 1214-1220.
12. Vergniol J, Foucher J, Terrebonne E etal. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140 (7): 1970-1979.
13. Mirault T, Lucidarme D, Turlin B etal. Non-invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload. Eur J Haematol 2008; 80 (4): 337-340.
14. Fraquelli M, Cassinerio E, Roghi A etal. Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol 2010; 85 (8): 564-568.
15. Mavrogeni SI, Gotsis ED, Markussis V etal. T2 relaxation time study of iron overload in b-thalassemia. MAGMA 1998; 6 (1): 7-12.
16. Wood JC, Enriquez C, Ghugre N etal. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106 (4): 1460-1465.
17. Pietrangelo A. Non-invasive assessment of hepatic iron overload: are we finally there? J Hepatol 2005; 42 (1): 153-154.
18. Gandon Y, Olivie D, Guyader D etal. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363 (9406): 357-362.
19. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24 (2): 289-293.
20. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000; 31 (1): 241-246.
21. Wai CT, Greenson JK, Fontana RJ etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38 (2): 518-526.
22. Sterling RK, Lissen E, Clumeck N etal. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43 (6): 1317-1325.
23. Vallet-Pichard A, Mallet V, Nalpas B etal. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007; 46 (1): 32-36.
24. Angelucci E, Muretto P, Nicolucci A etal. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002; 100 (1): 17-21.
25. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32 (3): 477-481.
26. Angelucci E, Baronciani D, Lucarelli G etal. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995; 89 (4): 757-761.
27. Angelucci E, Brittenham GM, McLaren CE etal. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343 (5): 327-331.
28. Stasi C, Arena U, Vizzutti F etal. Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool? Dig Liver Dis 2009; 41 (12): 863-866.
29. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008; 134 (1): 8-14.
30. Wood JC. Diagnosis and management of transfusion iron overload: the role of imaging. Am J Hematol 2007; 82 (12 Suppl): 1132-1135.
31. Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 1999; 212 (1): 227-234.
32. Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1996; 25 (2): 172-177.
33. Adhoute X, Foucher J, Laharie D etal. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol 2008; 32 (2): 180-187.
34. Takemoto R, Nakamuta M, Aoyagi Y etal. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection. J Dig Dis 2009; 10 (2): 145-148.